Axiom Investors LLC Dexcom Inc Transaction History

Axiom Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$80.99 - $107.93 $3.7 Million - $4.92 Million	-45,624 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $5.62 Million - $6.94 Million	-66,282 Reduced 59.23%	45,624 $16.4 Million
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $2.28 Million - $3.05 Million	29,225 Added 35.35%	111,906 $41.4 Million
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $7.9 Million - $9.34 Million	82,681 New	82,681 $34.1 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

Stay updated on Axiom Investors LLC with notifications on news.